Nutrinia Ltd.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Nutrinia Ltd.
Elgan Hopes Perseverance With Enteral Insulin For Preterm Infants Will Pay Off
The product improved GI function and reduced related complications, including life-threatening events, in a Phase III study despite an initial futility analysis. An exec stayed confident, acquired the product and plans to initiate a confirmatory trial.
Asia Executives To Watch: Gilead, BMS, AZ In Japan, WuXi NextCode
Multinational drug makers continue shuffling their senior management in Asia as Gilead Sciences has a new president for Japan, and so does Bristol-Myers Squibb. WuXi NextCode hires a new chief digital officer.
Execs On The Move, October 2016
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
VC Roundup: Moderna Seeks Another Record-Breaking Raise; Arcus Emerges From Stealth Mode
Having raised a precedent-setting $450m venture capital round in January 2015, Moderna is well on its way to a planned $600m additional fundraising. The privately held company is keeping quiet about what it's doing with all that cash. Tioma, Nutrina and Avelas are among other firms receiving VC financing.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Nutraceuticals
-
Drug Delivery
- Macromolecule
-
Biotechnology
- Large Molecule
-
Drug Discovery Tools
-
Molecular Diversity
- Natural Products
-
Molecular Diversity
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice